Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Feb 15 2026

Vaccines

Images
https://upload.medbullets.com/topic/121788/images/pediatric.jpg
https://upload.medbullets.com/topic/121788/images/adolescent.jpg
https://upload.medbullets.com/topic/121788/images/adult.jpg
https://upload.medbullets.com/topic/121788/images/contraindic.jpg
  • Snapshot
    • A 54-year-old man presents to her primary care physician for a worsening productive cough. His cough began approximately 2 months ago, and over the past week, he has been producing more yellow sputum. Medical history is significant for chronic obstructive pulmonary disease. He drinks occasionally and smokes 1-pack per day for the past 35 years. The patient is started on broad-spectrum antibiotics and receives 23-valent pneumococcal polysaccharide vaccine (PPSV23) due to his current cigarette use and chronic lung disease.
  • Vaccinations in Children (0-6 Years of Age)
      • Vaccinations in Children
      • Vaccine
      • Age
      • Comments
      • Hepatitis B
      • First dose within the first 24 hours of life
      •  Second dose at 1-2 months of age
      •  Third dose at 6-18 months of age
      • Subunit vaccine
      •  In HBsAg-positive mothers, the infant should receive the hepatitis B vaccine and hepatitis B immune globulin 
      • Rotavirus
      • First dose at 2 months
      • Second dose at 4 months
      • Third dose at 6 months
      • Live-attenuated vaccine
      • Can increase risk for intussusception
      • Diphtheria, tetanus, and/or pertussis
      • First dose at 2 months
      • Second dose at 4 months
      • Third dose at 6 months
      • Fourth dose at 15-18 months
      • Fifth dose at 4-6 years of age
      • Booster doses are given starting at 11 years of age
      • Inactivated vaccine
      • H. influenzae type b conjugate
      • First dose at 2 months
      •  Second dose at 4 months
      •  Third dose at 12-15 months
      • Inactivated vaccine
      • Pneumococcal conjugate (PCV 13)
      • First dose at 2 months
      •  Second dose at 4 months
      •  Third dose at 6 months
      •  Fourth dose at 12-15 months
      • Inactivated vaccine
      • Poliovirus
      • First dose at 2 months
      •  Second dose at 4 months
      •  Third dose at 6-18 months
      •  Fourth dose at 4-6 years 
      • Inactivated vaccine
      • Influenza
      • Annually ≥ 6 months of age
      • Intramuscular vaccine is an inactivated vaccine
      •  Intranasal vaccine is a live-attenuated vaccine
      • Measles, mumps, and rubella
      • First dose at 12-15 months
      •  Second dose at 4-6 years of age
      • Live-attenuated vaccine
      • Varicella
      • First dose at 12-15 months
      •  Second dose at 4-6 years of age
      • Live-attenuated vaccine
      • Hepatitis A
      • First dose at 12-24 months
      •  Second dose given at least 6 months after the first dose
      • Inactivated vaccine
  • Vaccinations in Adolescents (7-18 Years of Age)
      • Vaccinations In Adolescents 
      • Vaccine
      • Age
      • Comments
      • Tetanus, diphtheria, acellular pertussis (Tdap)
      • 11-12 years of age
      • Inactivated vaccine
      • Human papillomavirus
      • Two doses at 9-14 years of age
      • in patients between the ages of 9-14, the 2 dose are administered 6-12 months after the first dose
      •  Three doses at ≥ 15 years of age
      • given at 0, 1-2, and 6 months
      • Subunit vaccine
      •  Three doses of this vaccine are also recommended in immunocompromised adolescent patients
      • Meningococcal 
      • First dose at 11-12 years of age
      •  Second dose at 16 years of age
      • Inactivated vaccine
      • Influenza
      • First dose given at 7-10 years of age and then annually
      • Intramuscular vaccine is an inactivated vaccine
      •  Intranasal vaccine is a live-attenuated vaccine
  • Vaccinations in Adults (> 18 Years of Age)
      • Vaccinations in Adults
      • Vaccine
      • Age
      • Comments
      • Influenza
      • One dose annually
      • Inactivated vaccine
      •   In HBsAg-positive mothers, the infant should receive the hepatitis B vaccine and hepatitis B immune globulin 
      • Tetanus, diphtheria, acellular pertussis (Tdap) or tetanus and diphtheria (Td)
      • One dose Tdap and then a Td booster every 10 years
      • In pregnant women, 1 dose of Tdap should be given during each pregnancy between 27-36 weeks gestation
      • Varicella
      • Two doses 4-8 weeks apart if the patient is without immunity to varicella
      • Zoster
      • Two doses given 2-6 months apart at ≥ 50 years of age
      • Pneumococcal (PPSV23)
      • Given at least 1 year after PCV13 administration in adults ≥ 65 years of age
      •  PPSV23 is indicated in
      • - patients 19-64 years of age with the following
      • chronic heart disease (excluding hypertension)
      • chronic liver disease
      • chronic lung disease
      • diabetes mellitus
      • cigarette smoking
      • - patients ≥ 19 with
      • immunodeficiency disorders
      • HIV
      • anatomical or functional asplenia
      • chronic renal failure or nephrotic syndrome
      • cerebral spinal fluid leak
      • cochlear implant
      • PPSV23 is given after PCV13
      • PPSV23 is not conjugated and does not stimulate a helper T-cell response
flashcard locked
Create a free account or log in to see the cards.
Question
1 of 12
Infectious Disease | Vaccines
  • Infectious Dis.
  • - Vaccines
17:29 min
7/17/2021
222 plays
4.5
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
(2)
Private Note